Meningiomas are the most common primary intracranial tumors in adults and are increasing
in incidence due to the aging population and increased access to neuroimaging. While most …

Abstract Homozygous CDKN2A/B deletion has been associated with an increased risk of
recurrence in meningiomas. However, the evidence is confined to a limited number of …

Purpose Meningiomas classified as grade 2–3 according to the World Health Organisation
(WHO) require combined surgery and in most cases radiotherapy (RT). Their initial …

Objective Despite the lack of prospective evidence for the perioperative use of
dexamethasone in meningioma surgery, its use is well established in the daily routine of …

Simple Summary Meningiomas are classified pathologically by the World Health
Organization (WHO) grading system, with WHO grade 2 and 3 tumors considered “high …

Primary meningioma at extracranial head and neck sites is uncommon. Since fine needle
aspiration (FNA) is often the first line diagnostic modality for the evaluation of masses in the …

Abstract Background The World Health Organization 2021 classification introduces
molecular grading criteria for anaplastic meningiomas, including TERT promoter (TERTp) …

Purpose Grade 3 meningiomas, although rare, are associated with high morbidity and
mortality. The respective impacts of extent of surgical resection and adjuvant radiotherapy …

Abstract Aims WHO Grade 3 (G3) meningiomas are rare tumours with limited data to guide
management. This retrospective study documents UK management approaches across 14 …

Abstract Background. The World Health Organization 2021 classification introduces
molecular grading criteria for anaplastic meningiomas, including TERT promoter (TERTp) …